Publications by authors named "Takayuki Kanno"

Article Synopsis
  • Researchers investigated whether SARS-CoV-2 RNA can be found on the skin of COVID-19 patients by analyzing skin surface lipids (SSLs) collected from their faces.
  • Using RT-PCR, they found that 84.6% of samples tested positive within 5 days of symptom onset, while only 30.4% tested positive between 6-10 days.
  • The study also revealed an increase in specific genes related to the immune response in the skin samples, highlighting a new method for detecting the virus and studying its impact on human health non-invasively.
View Article and Find Full Text PDF
Article Synopsis
  • The isolation of SARS-CoV-2 from patient samples is crucial for accurate COVID-19 diagnosis and studying virus variants.
  • VeroE6 cells modified to overexpress human ACE2 and TMPRSS2 are more effective than standard VeroE6/TMPRSS2 cells, showing a 1.6-fold increase in virus isolation efficiency, especially for samples with low viral loads.
  • Experiments with VSV pseudoviruses indicate that these modified cells enhance infectivity rates, emphasizing the need for selecting optimal cell cultures when studying SARS-CoV-2.
View Article and Find Full Text PDF

COVID-19, caused by SARS-CoV-2 infection, results in irreversible or fatal lung injury. We assumed that necroptosis of virus-infected alveolar epithelial cells (AEC) could promote local inflammation and further lung injury in COVID-19. Since CD8+ lymphocytes induced AEC cell death via cytotoxic molecules such as FAS ligands, we examined the involvement of FAS-mediated cell death in COVID-19 patients and murine COVID-19 model.

View Article and Find Full Text PDF

The severity of COVID-19 has been reported to differ among SARS-CoV-2 mutant variants. The overactivation of macrophages is involved in severe COVID-19, yet the effects of SARS-CoV-2 mutations on macrophages remain poorly understood. To clarify the effects, we examined whether mutations of spike proteins (S-proteins) affect macrophage activation.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the LC16m8 vaccine's safety and effectiveness against the monkeypox virus (MPXV) in 50 healthy adults over 168 days.
  • On day 28, the vaccine showed strong immunogenicity, with 72% to 88% seroconversion rates, although these rates declined by day 168.
  • Adverse events were common but mostly mild, and no serious safety issues or cases of monkeypox were reported during the study period.
View Article and Find Full Text PDF
Article Synopsis
  • Immunocompromised patients with hematologic malignancies, particularly those on anti-CD20 treatments like rituximab, face a higher risk of prolonged SARS-CoV-2 infection, and antiviral therapy may improve outcomes.
  • A case study details a 68-year-old man who developed acute acalculous cholecystitis after extended treatment with a specific antiviral combination (nirmatrelvir/ritonavir) for persistent COVID-19 following lymphoma treatment.
  • The study suggests that ongoing antiviral therapy, along with COVID-19, might lead to complications like elevated liver enzymes and cholecystitis, highlighting the need for careful monitoring during treatment.
View Article and Find Full Text PDF

Infectious virus shedding from individuals infected with severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is used to estimate human-to-human transmission risk. Control of SARS-CoV-2 transmission requires identifying the immune correlates that protect infectious virus shedding. Mucosal immunity prevents infection by SARS-CoV-2, which replicates in the respiratory epithelium and spreads rapidly to other hosts.

View Article and Find Full Text PDF

A dual-isotope simultaneous acquisition (DISA) of Tc and F affects the image quality of Tc by crosstalk and spill-over from F. We demonstrated the influence of spill-over and crosstalk on image quality and its correction effect for DISA SPECT with Tc and F. A fillable cylindrical chamber of 30 mm with NEMA-NU4 image quality phantom was filled with Tc only or a mixed Tc and F solution (C).

View Article and Find Full Text PDF
Article Synopsis
  • Transplanting human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) shows promise for treating heart failure, but there's a need for reliable long-term monitoring methods post-transplant.* -
  • The study introduced a sodium/iodide symporter (NIS) into human iPSCs and used nuclear medicine imaging to track the engraftment of these cells in immunodeficient rats over time.* -
  • NIS-expressing iPSC-CMs were successfully tracked with imaging, but it was found that NIS expression impacted the growth and proliferation of the cells, indicating the need for more research on its effects.*
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the relationship between COVID-19 antibody levels (S-IgG) and the ability to neutralize the virus in individuals who were either infected or vaccinated.
  • Researchers analyzed serum samples from 457 individuals, including both COVID-19 patients and healthcare workers vaccinated with BNT162b2, to assess antibody dynamics.
  • Findings suggested that while S-IgG levels correlated with neutralizing activity, they cannot be solely relied upon to predict effective immunity, highlighting limitations in using antibody tests for diagnosis and treatment decisions.
View Article and Find Full Text PDF

Obesity has been recognized as one of the most significant risk factors for the deterioration and mortality associated with COVID-19, but the significance of obesity itself differs among ethnicity. Multifactored analysis of our single institute-based retrospective cohort revealed that high visceral adipose tissue (VAT) burden, but not other obesity-associated markers, was related to accelerated inflammatory responses and the mortality of Japanese COVID-19 patients. To elucidate the mechanisms how VAT-dominant obesity induces severe inflammation after severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection, we infected two different strains of obese mice, C57BL/6JHamSlc-ob/ob (ob/ob), C57BLKS/J-db/db (db/db), genetically impaired in the leptin ligand and receptor, respectively, and control C57BL/6 mice with mouse-adapted SARS-CoV-2.

View Article and Find Full Text PDF
Article Synopsis
  • A study evaluated how well the serum from individuals who had breakthrough infections with different SARS-CoV-2 variants could neutralize those variants, which is key for creating better COVID-19 booster vaccines.
  • The research used Bayesian hierarchical modeling to analyze the effects of the time period between vaccination and infection, finding that different variants require different durations (2-4 months) to achieve optimal immune response saturation.
  • The findings emphasize the need for longer vaccine dosage intervals (at least 4 months) to effectively enhance the immune response against various Omicron variants, regardless of their genetic differences from the original strain.
View Article and Find Full Text PDF
Article Synopsis
  • Immune responses to SARS-CoV-2 variants are affected by prior infections and vaccinations, which can influence the effectiveness of booster shots.
  • Higher viral loads and longer intervals between vaccination and infection lead to better neutralizing activity against variants like Omicron BA.4/5.
  • Optimizing the timing of booster doses and designing targeted antigens are crucial for developing vaccines that can effectively combat diverse SARS-CoV-2 variants.
View Article and Find Full Text PDF

Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is being increasingly recognized as a severe complication that contributes to poor prognoses among patients with COVID-19. However, little is known regarding the clinical course of CAPA with hematological malignancies, especially after allogeneic hematopoietic stem cell transplantation (HSCT). A 29-year-old woman was diagnosed with proven CAPA with an Aspergillus fumigatus identified by cultures of bronchoalveolar lavage and lung biopsy four years after haploidentical HSCT for acute myelogenous leukemia.

View Article and Find Full Text PDF

Background: Myocardial phantom studies are widely used as a tool to accurately assess the physical phenomenon of dual-isotope simultaneous acquisition (DISA) in the small-animal fields. However, the previous phantom did not reproduce the structures of rats or mice. The aim of this study was to develop a novel myocardial phantom simulating the structure of a small animal that can be evaluated using the image quality of DISA.

View Article and Find Full Text PDF

Quantitative measurement of SARS-CoV-2 neutralizing antibodies is highly expected to evaluate immune status, vaccine response, and antiviral therapy. The Elecsys® Anti-SARS-CoV-2 S (Elecsys® anti-S) was developed to measure anti-SARS-CoV-2 S proteins. We sought to investigate whether Elecsys® anti-S can be used to predict neutralizing activities in patients' serums using an authentic virus neutralization assay.

View Article and Find Full Text PDF

To control the coronavirus disease 2019 (COVID-19) pandemic, there is a need to develop vaccines to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. One candidate is a nasal vaccine capable of inducing secretory IgA antibodies in the mucosa of the upper respiratory tract, the initial site of infection. However, regarding the development of COVID-19 vaccines, there is concern about the potential risk of inducing lung eosinophilic immunopathology as a vaccine-associated enhanced respiratory disease as a result of the T helper 2 (Th2)-dominant adaptive immune response.

View Article and Find Full Text PDF

COVID-19 antibody testing has been developed to investigate humoral immune response in SARS-CoV-2 infection. To assess the serological dynamics and neutralizing potency following SARS-CoV-2 infection, we investigated the neutralizing (NT) antibody, anti-spike, and anti-nucleocapsid antibodies responses using a total of 168 samples obtained from 68 SARS-CoV-2 infected patients. Antibodies were measured using an authentic virus neutralization assay, the high-throughput laboratory measurements of the Abbott Alinity quantitative anti-spike receptor-binding domain IgG (S-IgG), semiquantitative anti-spike IgM (S-IgM), and anti-nucleocapsid IgG (N-IgG) assays.

View Article and Find Full Text PDF

There have been several reports of breakthrough infections, which are defined as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among individuals who had received at least two doses of vaccine at least 14 days before the onset of infection, but data on the antibody titers, including SARS-CoV-2 neutralizing antibody activity, and the clinical course of individuals with breakthrough infections are limited. We encountered a case of breakthrough infection with the SARS-CoV-2 delta variant in a 31-year-old female healthcare worker (the index case, Case 1) and a secondary case (Case 2) in her unvaccinated 33-year-old husband. We studied the role of the anti-spike immunoglobulin G (IgG) and neutralizing antibody activity in the two case patients.

View Article and Find Full Text PDF

To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29-December 18, 2021. Vaccinees with mild or asymptomatic infection shed infectious virus 6-9 days after onset or diagnosis, even after symptom resolution.

View Article and Find Full Text PDF

Background: Kawasaki disease (KD) is an acute, febrile, systemic vasculitis of unknown etiology that primarily affects the coronary arteries and generally occurs at around 1 year of age. Although the diagnosis of KD is generally not difficult, it is challenging in cases of incomplete KD lacking characteristic clinical manifestations. The incidence of incomplete KD is higher in infants younger than 6 months of age.

View Article and Find Full Text PDF
Article Synopsis
  • The immune response to SARS-CoV-2 has become complex due to vaccinations and various infections, leading to diverse protective immunity in populations, especially with the emergence of the highly mutated Omicron variant.!* -
  • A study assessed how well different immune histories neutralized Omicron using blood samples from mRNA vaccinees and those with prior Alpha/Delta infections, finding that breakthrough infections enhanced neutralization against Omicron.!* -
  • Results showed that fully vaccinated individuals without breakthrough infections were less able to neutralize Omicron, while those with breakthrough infections produced stronger antibodies, emphasizing the importance of the vaccination-infection timing in determining immune response efficacy.!*
View Article and Find Full Text PDF

Corticosteroids are widely used to treat severe COVID-19, but in immunocompromised individuals, who are susceptible to persistent infection, long term corticosteroid use may delay viral clearance. We present a case of prolonged SARS-CoV-2 infection in a man with significantly impaired B-cell immunity due to non-Hodgkin lymphoma which had been treated with rituximab. SARS-CoV-2 shedding persisted, despite treatment with remdesivir.

View Article and Find Full Text PDF
Article Synopsis
  • Antibody levels against SARS-CoV-2 decrease over time, but their ability to neutralize the virus improves as the immune response matures.
  • A study of convalescent plasma showed that while total antibody levels declined, the potency of these antibodies against the original virus increased significantly.
  • Late-stage antibodies demonstrated better effectiveness against emerging variants like B.1.351 and P.1, indicating that even as overall antibody levels drop, protection against the virus may still be maintained.
View Article and Find Full Text PDF

Intestinal anisakiasis is not only a rare but also a difficult to diagnose parasitic disease. The symptoms are not specific and are often severe and abrupt; therefore, patients are sometimes diagnosed as having surgical abdomen. The clinical imaging findings are remarkable, including ascites, enteritis, ileus, eosinophilic granuloma and sometimes perforation.

View Article and Find Full Text PDF